KR910004599A - 1,3-디하이드로-1-(피리디닐아미노)-2h-인돌-2-온, 이들의 제조방법 및 이들의 약제로서의 용도 - Google Patents

1,3-디하이드로-1-(피리디닐아미노)-2h-인돌-2-온, 이들의 제조방법 및 이들의 약제로서의 용도 Download PDF

Info

Publication number
KR910004599A
KR910004599A KR1019900011818A KR900011818A KR910004599A KR 910004599 A KR910004599 A KR 910004599A KR 1019900011818 A KR1019900011818 A KR 1019900011818A KR 900011818 A KR900011818 A KR 900011818A KR 910004599 A KR910004599 A KR 910004599A
Authority
KR
South Korea
Prior art keywords
compound
lower alkyl
indol
dihydro
pharmaceutically acceptable
Prior art date
Application number
KR1019900011818A
Other languages
English (en)
Other versions
KR0169108B1 (ko
Inventor
챨스 에플랜드 리챠드
고든 웨틀라우퍼 데이비드
Original Assignee
훽스트-러셀 파마슈티칼즈 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 훽스트-러셀 파마슈티칼즈 인코포레이티드 filed Critical 훽스트-러셀 파마슈티칼즈 인코포레이티드
Publication of KR910004599A publication Critical patent/KR910004599A/ko
Priority to KR1019980024262A priority Critical patent/KR0175639B1/ko
Application granted granted Critical
Publication of KR0169108B1 publication Critical patent/KR0169108B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Abstract

내용 없음.

Description

1,3-디하이드로-1-(피리디닐아미노)-2H-인돌-2-온, 이들의 제조방법 및 이들의 약제로서의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (14)

  1. 하기 일반식(I)의 화합물, 이의 약제학적으로 허용되는 산부가염 및, 적용되는 경우, 이의 광학적, 기하학적 및 입체 이성체 및 이들의 라세미체 혼합물.
    상기식에서, R1, R2및 R3는 독립적으로 수소, 저급 알킬, 아릴 또는 아릴저급알킬이거나, 피리디닐메틸, 피리디닐에틸, 티에닐메틸 및 티에닐에틸로 이루어진 그룹중에서 선택된 헤테로아릴저급알킬이거나, R2및 R3은 함께 탄소수 4 내지 6의 사이클로알칸 환 또는 피페리딘 및 테트라하이드록피란으로 이루어진 그룹중에서 선택된 스피로-융합된 아릴 사이클로알칸 또는 헤테로사이클로알킬을 형성하고, X 및 Y는 독립적으로 수소, 할로겐 하이드록시, 저급알킬, 저급 알콕시, 니트로, 아미노 또는 트리플루오로메틸이고, m 및 n은 독립적으로 1 내지 3의 정수이다.
  2. 제1항에 있어서, R1이 수소 또는 저급알킬이고, X 및 Y가 독립적으로 수소, 할로겐 또는 저급 알콕시이며, m 및 n이 1인 화합물.
  3. 제2항에 있어서, R2및 R3가 독립적으로 수소, 저급알킬 또는 헤테로아릴저급알킬이거나, R2및 R3이 함께 탄소수 4 내지 6의 사이클로알칸환, 피페리딘 및 테트라하이드로피란으로 이루어진 그룹 중에서 선택된 헤테로사이클로알킬 또는 스피로-융합된 아릴 사이클로알칸을 형성하는 화합물.
  4. 제3항에 있어서, R2및 R3이 독립적으로 수소, 저급 알킬인 화합물.
  5. 제1항에 있어서, 1,3-디하이드로-1-(프로필-4-피리디닐아미노)-2H-인돌-2-온 또는 이의 약제학적으로 허용되는 산 부가염인 화합물.
  6. 제1항에 있어서, 1,3-디하이드로-1-(4-피리디닐아미노)-2H-인돌-2-온 또는 이의 약제학적으로 허용되는 산 부가염인 화합물.
  7. 제1항에 있어서, 1,3-디하이드로-3,3-디메틸-1-(프로필-4-피리디닐아미노)-2H-인돌-2-온 또는 이의 약제학적으로 허용되는 산 부가염인 화합물.
  8. 제1항에 있어서, 1,3-디하이드로-1-[(3-플루오로-4-피리디닐)아미노]-3-메틸-2H-인돌-2-온 또는 이의 약제학적으로 허용되는 산 부가염인 화합물.
  9. 제1항에 있어서, 1,3-디하이드로-3,3-디메틸-1-[4-(3-플루오로피리디닐)-프로필아미노]-2H-인돌-2-온 또는 이의 약제학적으로 허용되는 산 부가염인 화합물.
  10. 제1항에 있어서, 1,3-디하이드로-1-[(3-플루오로-4-피리디닐)-프로필아미노]-2H-인돌-2-온 또는 이의 약제학적으로 허용되는 산 부가염인 화합물.
  11. 일반식(II)의 화합물.
    상기식에서, R2, R3, Y 및 n은 제1항에서 정의한 바와 같고, 단, R2, R3및 Y가 수소이고 n이 1인 경우는 제외한다.
  12. 활성성분으로서 제1항 또는 11항의 화합물 및 이에 적합한 담체를 함유함을 특징으로 하는 약제학적 조성물.
  13. 진통활성, 진경활성 및/또는 기억증강활성을 갖는 약제를 제조하기 위란 제1항 또는 제11항의 화합물의 용도.
  14. 일반식(III)의 화합물을 일반식(IV)의 화합물과 반응시킴을 특징으로 하여, 제1항에 따른 일반식(I)의 화합물을 제조하는 방법.
    상기식에서, R1, R2, R3, Y, n, X 및 m은 제1항에서 정의한 바와 같고, Hal은 할로겐이며, p는 1 또는 2이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900011818A 1989-08-02 1990-08-01 1,3-디하이드로-1-(피리디닐아미노)-2h-인돌-2-온, 이의 제조방법 및 이를 포함하는 약제학적 조성물 KR0169108B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019980024262A KR0175639B1 (en) 1989-08-02 1998-06-26 1,3-dihydro-1-amino-2h-indol-2-ones

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US388437 1989-08-02
US388,437 1989-08-02
US07/388,437 US5006537A (en) 1989-08-02 1989-08-02 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US535640 1990-06-11
US07/535,640 US5053511A (en) 1989-08-02 1990-06-11 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-ones
US535,640 1990-06-11

Publications (2)

Publication Number Publication Date
KR910004599A true KR910004599A (ko) 1991-03-29
KR0169108B1 KR0169108B1 (ko) 1999-01-15

Family

ID=27012314

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019900011818A KR0169108B1 (ko) 1989-08-02 1990-08-01 1,3-디하이드로-1-(피리디닐아미노)-2h-인돌-2-온, 이의 제조방법 및 이를 포함하는 약제학적 조성물
KR1019980024262A KR0175639B1 (en) 1989-08-02 1998-06-26 1,3-dihydro-1-amino-2h-indol-2-ones

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019980024262A KR0175639B1 (en) 1989-08-02 1998-06-26 1,3-dihydro-1-amino-2h-indol-2-ones

Country Status (18)

Country Link
US (2) US5006537A (ko)
EP (1) EP0415102B1 (ko)
JP (1) JPH0674265B2 (ko)
KR (2) KR0169108B1 (ko)
AT (1) ATE118001T1 (ko)
AU (2) AU628202B2 (ko)
CA (1) CA2022486C (ko)
DE (1) DE69016530T2 (ko)
DK (1) DK0415102T3 (ko)
ES (1) ES2068293T3 (ko)
FI (1) FI903819A0 (ko)
GR (1) GR3015227T3 (ko)
IE (1) IE67045B1 (ko)
IL (1) IL95252A0 (ko)
NO (1) NO903389L (ko)
NZ (1) NZ234725A (ko)
PT (1) PT94879B (ko)
ZA (1) ZA906050B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100507145B1 (ko) * 2002-06-20 2005-08-09 현대자동차주식회사 차량의 전원제어장치

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US5296488A (en) * 1989-08-02 1994-03-22 Hoechst-Roussel Pharmaceuticals Inc. Method of using 2,3-dihydro-1-(pyridinylamino)-indoles as anticonvulsants and for the enhancement of memory
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5076835A (en) * 1990-05-31 1991-12-31 America Cyanamid Company Aryloxyspiroalkylindolinone herbicides
US5102891A (en) * 1990-07-23 1992-04-07 Hoechst-Roussel Pharmaceuticals Inc. 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
US5214038A (en) * 1991-04-15 1993-05-25 Hoechst-Roussel Pharmaceuticals Inc. 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof
US5185350A (en) * 1991-09-23 1993-02-09 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles
US5246947A (en) * 1991-09-23 1993-09-21 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1,2-benzisothiazoles and their use for treating depression
AU3425493A (en) * 1992-01-16 1993-08-03 Du Pont Merck Pharmaceutical Company, The Novel neurotransmitter releasers useful for cognition enhancement
RU2051151C1 (ru) * 1992-01-16 1995-12-27 Дзе Дюпон Мерк Фармасьютикал Компани Азотсодержащие гетероциклические производные флуорена
US5278162A (en) * 1992-09-18 1994-01-11 The Du Pont Merck Pharmaceutical Company 3,3'-disubstituted-1,3-dihydro-2H-pyrrolo[2,3-b]heterocyclic-2-one useful in the treatment of cognitive disorders of man
US5296478A (en) * 1992-10-07 1994-03-22 The Dupont Merck Pharmaceutical Co. 1-substituted oxindoles as cognition enhancers
FR2708606B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
AU1884595A (en) * 1994-04-29 1995-11-29 Pfizer Inc. Novel acyclic and cyclic amides as neurotransmitter release enhancers
HUP9802413A3 (en) * 1995-07-27 2002-02-28 Aventis Pharmaceuticals Inc Br Use of n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents and for the preparation of a pharmaceutical composition for the treatment of convulsions
DE69707659T2 (de) * 1996-04-12 2002-05-08 Aventis Pharma Inc Isatinderivate als acetylcholinesterase-inhibitoren und analgetika
US6100276A (en) * 1996-04-12 2000-08-08 Aventis Pharmaceuticals Inc. Isatin derivatives as acetylcholinesterase inhibitors and analgesics
WO1998029407A2 (en) * 1996-12-27 1998-07-09 Hoechst Marion Roussel, Inc. N-(pyridinylamino)isoindolines for treating alzheimer's and depression

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260767A (en) * 1979-12-26 1981-04-07 American Cyanamid Company 2-Pyridylhydrazides
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
ATE115143T1 (de) * 1987-04-24 1994-12-15 Hoechst Roussel Pharma N-(pyridinyl)-1h-indol-1-amine, verfahren zu deren herstellung und ihre verwendung als arzneimittel.
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100507145B1 (ko) * 2002-06-20 2005-08-09 현대자동차주식회사 차량의 전원제어장치

Also Published As

Publication number Publication date
NO903389D0 (no) 1990-08-01
DE69016530T2 (de) 1995-07-06
DE69016530D1 (de) 1995-03-16
FI903819A0 (fi) 1990-07-31
CA2022486C (en) 2001-04-03
AU1963092A (en) 1992-10-01
JPH0674265B2 (ja) 1994-09-21
PT94879A (pt) 1991-04-18
IL95252A0 (en) 1991-06-10
US5053511A (en) 1991-10-01
IE902787A1 (en) 1991-02-27
EP0415102B1 (en) 1995-02-01
EP0415102A1 (en) 1991-03-06
KR0169108B1 (ko) 1999-01-15
NZ234725A (en) 1992-12-23
US5006537A (en) 1991-04-09
ZA906050B (en) 1991-05-29
KR0175639B1 (en) 1999-10-01
JPH03118377A (ja) 1991-05-20
AU6000490A (en) 1991-02-07
ES2068293T3 (es) 1995-04-16
GR3015227T3 (en) 1995-05-31
DK0415102T3 (da) 1995-06-19
AU628202B2 (en) 1992-09-10
AU641595B2 (en) 1993-09-23
NO903389L (no) 1991-02-04
CA2022486A1 (en) 1991-02-03
IE67045B1 (en) 1996-02-21
PT94879B (pt) 1997-08-29
ATE118001T1 (de) 1995-02-15

Similar Documents

Publication Publication Date Title
KR910004599A (ko) 1,3-디하이드로-1-(피리디닐아미노)-2h-인돌-2-온, 이들의 제조방법 및 이들의 약제로서의 용도
KR910006277A (ko) N-치환된-4-피리미딘아민 및 피리미딘디아민, 이의 제조방법 및 약제로서의 이의 용도
KR850003402A (ko) 2-아미노-5-하이드록시-4-메틸 피리미딘 유도체의 제조방법
KR880002834A (ko) α-알킬-4-아미노-3-퀴놀린메탄올 및 1-(4-아르알킬아미노-3-퀴놀리닐) 알칸온, 이의 제조방법 및 약제로서의 용도
DE69519667T2 (de) Verfahren zur stabilisierung von duocarmycinderivaten
JP2006501181A5 (ko)
CA2011346A1 (en) 2-(1-piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same
KR880011199A (ko) 신규 펩타이드 화합물, 그의 제조방법 및 그를 함유하는 약학적 조성물
KR890008137A (ko) 3-[4(1-치환된-4-피페라지닐)부틸]-4-티아졸리디노 이의 제조방법 및 약제로서의 이의 용도
KR890008155A (ko) 신규인 유도체, 그 제조방법 및 의약에서의 사용
DK162992C (da) Analogifremgangsmaade til fremstilling af 1-piperazinyl-3-phenyl-indanderivater eller syreadditionssalte deraf
KR900007419A (ko) 1-[모노-또는 비스(트리플루오로메틸)-2-피리디닐]피페라진을 함유한 약학조성물
KR890001957A (ko) N-아미노부틸-n-페닐아릴아미드 유도체, 그의 제법 및 치료에의 응용
IE870004L (en) Optically pure compounds.
KR910009672A (ko) 피리다진 유도체, 이의 제조방법 및 이것을 함유하는 약학 조성물
KR910004597A (ko) 1-(피리디닐아미노)-2-피롤리디논, 이의 제조방법 및 약제로서의 이의 용도
ATE59632T1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate
KR890016017A (ko) 치환된 1-(1h-이미다졸-4-일)알킬-벤즈아미드
KR910004598A (ko) 2,3-디하이드로-1-(피리디닐아미노)-인돌, 이의 제조방법 및 약제로서 이의 용도
RU94026094A (ru) Применение феналкиламинов
ATE239711T1 (de) Neue allythiopyridazinderivate und verfahren zu ihrer herstellung
EA199800155A1 (ru) Новое соединение
KR900001691A (ko) 피리다지논 유도체
RU2205829C2 (ru) Замещенное производное циклобутиламина, антибактериальный агент и фармацевтическая композиция на его основе
FR2804958B1 (fr) Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20110921

Year of fee payment: 14

LAPS Lapse due to unpaid annual fee